Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-25-053091

Chief Development Officer sold 2,974 shares at $7.17 ($21,324)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kaiser Peter · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-23 Sale : show line 1 in the form 10b5-1 −2,974 $7.17 $21,324 207,104 D
Open-market sales · 2,974 sh · avg $7.17 · $21,324
Loading xslF345X05/tm2516174-3_4seq1.xml…